XML 31 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 8 - Segment Information (Tables)
6 Months Ended
Sep. 30, 2014
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]

Three Months Ended September 30, 2014

 

Medical

   

Industrial

   

Adjustments*

   

Consolidated

 

Net sales

  $ 3,267     $ 843     $ -     $ 4,110  

Gross profit

    1,023       235       -       1,258  

Operating loss

    (1,435

)

    (6

)

    -       (1,441

)

Interest expense, net

    (106 )     -       -       (106 )

Depreciation and amortization

    151       1       -       152  

Stock-based compensation expense

    186       9       -       195  

Expenditures for fixed assets

    (8 )     -       -       (8 )
                                 

As of September 30, 2014

                               

Total assets

    10,542       1,865       (2,358

)

    10,049  
                                 

Three Months Ended September 30, 2013

                               

Net sales

  $ 3,399     $ 569     $ -     $ 3,968  

Gross profit

    981       214       -       1,195  

Operating loss

    (1,345

)

    62       -       (1,283

)

Interest expense, net

    (44 )     -       -       (44 )

Depreciation and amortization

    170       3       -       173  

Stock-based compensation expense

    (221

)

    (6 )     -       (227

)

Expenditures for fixed assets

    46       -       -       46  
                                 

As of September 30, 2013

                               

Total assets

    11,240       1,333       (1,840

)

    10,733  

Six Months Ended September 30, 2014

 

Medical

   

Industrial

   

Adjustments*

   

Consolidated

 

Net sales

  $ 6,327     $ 1,535     $ -     $ 7,862  

Gross profit

    1,921       486       -       2,407  

Operating loss

    (3,273

)

    (46

)

    -       (3,319

)

Interest expense, net

    (189 )     -       -       (189 )

Depreciation and amortization

    314       4       -       318  

Stock-based compensation expense

    328       21       -       349  

Expenditures for fixed assets

    17       -       -       17  
                                 

Six Months Ended September 30, 2013

                               

Net sales

  $ 6,428     $ 1,192     $ -     $ 7,620  

Gross profit

    1,774       501       -       2,275  

Operating loss

    (3,732

)

    60       -       (3,672

)

Interest expense, net

    (85 )     -       -       (85 )

Depreciation and amortization

    355       7       -       362  

Stock-based compensation expense

    309       19       -       328  

Expenditures for fixed assets

    46       -       -       46  
   

As of September 30,

 

* Adjustments

 

2014

   

2013

 

Intercompany eliminations

  $ (1,672

)

  $ (1,154

)

Investment in subsidiaries

    (686

)

    (686

)

Total adjustments

  $ (2,358

)

  $ (1,840

)

Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]
   

As of September 30,

 

* Adjustments

 

2014

   

2013

 

Intercompany eliminations

  $ (1,672

)

  $ (1,154

)

Investment in subsidiaries

    (686

)

    (686

)

Total adjustments

  $ (2,358

)

  $ (1,840

)